Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05402501
Other study ID # 2021.0089
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 15, 2021
Est. completion date November 2024

Study information

Verified date May 2022
Source Amsterdam UMC, location VUmc
Contact Brigit de Jong, Dr.
Phone +31204442834
Email b.dejong@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The LIMS study is an observational study that investigates the effectiveness of an online lifestyle program for patients with multiple sclerosis (MS). The patients will be monitored during 27 months, starting 3 months prior to the start of the lifestyle program.


Description:

This study aims to investigate the effect of an online lifestyle program on the impact of multiple sclerosis (MS) on daily functioning. MS patients will participate in the online lifestyle intervention of Voeding Leeft and will complete online questionnaires at 7 time-points: 3 months before the start of the intervention (run-in), before the start of the intervention (baseline), and 3, 6, 12, 18 and 24 months after the start of the intervention. A subsample (n=200) will also take part in measurements through mobile applications. The investigators hypothesize that the lifestyle program will reduce the impact of MS on the patients' daily functioning.


Recruitment information / eligibility

Status Recruiting
Enrollment 900
Est. completion date November 2024
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Eligibility criteria to participate in the online lifestyle intervention: Inclusion Criteria: - MS diagnosis - Motivated to adapt their lifestyle - Able to complete online questionnaires by themselves - Able to do grocery shopping and to (let someone) prepare the meals from the program - In a subpopulation (n=200): daily use of a smartphone Exclusion Criteria: - Not able to participate in an online lifestyle intervention (e.g. not having an email address, laptop/computer, internet) - An inability to speak or read Dutch - Vegan diet - Not willing to eat fish - BMI <18.5 and >35 kg/m2 - Pregnant or breastfeeding - Diagnosis of an eating disorder or psychiatric disorder (according to the DSM-V criteria) - History of bariatric surgery - Another disorder, such as inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis), cardiovascular disease (e.g. severe heart failure), malignancy, diabetes type 1 and 2 - Having previously participated in a lifestyle intervention of Voeding Leeft or currently participating in another lifestyle program or lifestyle study. - Currently under treatment at a dietician or lifestyle coach

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle intervention program "Leef! met MS"
The lifestyle program consists of a three-months intensive program, followed by a 21-months 'inspiration' program with occasional meetings.

Locations

Country Name City State
Netherlands Amsterdam UMC, location VUmc Amsterdam Noord-Holland

Sponsors (3)

Lead Sponsor Collaborator
Amsterdam UMC, location VUmc National MS Foundation, The Netherlands, Voeding Leeft

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Multiple Sclerosis Impact Scale (MSIS-29) Questionnaire that measures the impact of MS on their daily functioning Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary 12-item Short Form Health Survey (SF-12) Questionnaire that measures quality of life Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary EuroQol 5 Dimensions Questionnaire (EQ-5D) Questionnaire that measures quality of life Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary BMI BMI in kg/m^2 Assessed at 7 time-points during 27 months Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Waist circumference Waist circumference in centimeters Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Bristol stool chart Tool used to indicate stool type Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Medical Consumption Questionnaire (iMCQ) Questionnaire that measures health-care consumption Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Hospital Anxiety and Depression Scale (HADS) Questionnaire that measures symptoms of depression and anxiety Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Checklist Individual Strength-20-r (CIS-20) Questionnaire that measures the level of fatigue Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Multiple Sclerosis Neuropyschological Screening Questionnaire - patient version (MSNQ-P) Questionnaire that measures the level of subjective cognitive complaints Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Medical Outcomes Study Sleep Scale (MOS-ss) Questionnaire that measures sleep quality Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Dutch Norm for Healthy Physical Activity (In Dutch: Nederlandse Norm voor Gezond Bewegen (NNGB)) Questionnaire that measures the level of physical activity Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Perceived stress scale (PSS) Questionnaire that measures the level of perceived stress Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary iMTA Productivity Cost Questionnaire (iPCQ) Questionnaire that measures work productivity and the frequency of sick leave Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary Neurokeys keyboard app Only in a subsample (n=200); Real-world keystroke dynamics collected by smartphone technology. Continuous measures during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary MS sherpa app - Smartphone-adapted Symbol Digit Modalities Test (sSDMT) Only in a subsample (n=200); Patients will use the MS sherpa app to perform a smartphone-adapted Symbol Digit Modalities Test (sSDMT) on their mobile phone. Weekly tests during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary MS sherpa app - Smartphone-adapted two-minute walking test Only in a subsample (n=200); Patients will use the MS sherpa app to perform a two-minute walking test outside. Weekly tests during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
Secondary MS sherpa app - questionnaire Only in a subsample (n=200); Patients will use the MS sherpa app to answer seven questions on a likert-scale (e.g. about pain, stress, energy, memory) within the mobile application. Weekly questionnaire during a period of 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4